British pharmaceutical company, GlaxoSmithKline is seeking approval of the world's first anti-malaria vaccination. GSK scientists have reportedly spent nearly three decades developing the vaccine and now hope it will be widely available by 2016.
Malaria is a mosquito-borne disease that kills hundreds of thousands of people worldwide every year. While most anti-malaria medication is highly effective, scientists say a vaccine is the only way to truly eradicate the disease.
In a trial conducted in Africa, the vaccine, known as ‘RTS,S’ almost halved the number of malaria cases in young children and reduced the number of cases in infants by approximately 25%. It was Africa's largest clinical trial yet, involving almost 15,500 children across seven countries.
“A malaria vaccine has the potential to save hundreds of thousands of lives in the developing...